Summary Dysfunction of the cadherin-catenin complex, a key component of adherens junctions, is thought to confer invasive potential to cells. The aim of this study is to examine the expression and function of the E-cadherin/catenin complex in gastric carcinoma cell lines. Expression of E-cadherin, α, β and γ-catenin and p120 ctn , and of the adenomatous polyposis coli protein (APC), together with function of the cadherin-catenin complex was examined in a panel of gastric carcinoma cell lines, using immunocytochemistry, Western blotting and a cell-cell aggregation assay. Protein interactions were examined by sequential immunoprecipitation and immunoblotting with antibodies to E-cadherin, α, β and γ-catenin, p120 ctn and APC. Abnormalities of E-cadherin, α-and β-catenin expression, were associated with disturbance of E-cadherin-catenin complex composition, loss of membranous localization and loss of calcium-dependent aggregation in six gastric carcinoma cell lines. APC protein expression and interaction with β-catenin was preserved in five cell lines. We demonstrate frequent abnormalities of expression and function of E-cadherin and catenins, and associated disturbance of E-cadherin-mediated intercellular adhesion in gastric carcinoma cell lines. These findings support the tumour suppressor role of the E-cadherin and its contribution to the development and progression of the neoplastic phenotype in gastric carcinoma.
E-cadherin is a calcium-dependent cell-cell adhesion molecule, which forms the key functional component of adherens junctions of all epithelial cells. It interacts with E-cadherin molecules on adjacent epithelial cells forming an adhesive structure, which has been likened to an intercellular zipper (Shapiro et al, 1995) . It plays a key role in the establishment and maintenance of intercellular adhesion, cell polarity and tissue architecture (Takeichi, 1991) . Translation of intercellular contact signals into cellular organization is thought to be mediated by the catenins, which are key regulatory molecules in this mechanism. α-catenin (102 kDa), β-catenin (94 kDa) and γ-catenin (82 kDa), are membrane undercoat proteins which, through a series of interactions, link the cytoplasmic carboxy-terminal tail of E-cadherin to the actin cytoskeleton (Nagafuchi and Takeichi, 1989) .
α-catenin is homologous to Vinculin, a protein localized to focal contacts and adherens junctions, and known to play a role in linking these junctions to the actin cytoskeleton (Geiger et al, 1980 ). β-catenin shows homology to the product of the Drosophila segment polarity gene armadillo, and is an important component of the Wingless-Wnt signalling cascade (Gumbiner, 1995; Peifer, 1995) . Its role in signal transduction is independent of its adhesive function or role in transcriptional regulation (Behrens et al, 1996) . β-catenin also interacts with the epidermal growth factor receptor (EGFR) (Hoschuetzky, 1994) , and the proto-ongcogene c-erbB2 (Ochiai et al, 1994) , both members of the type I growth factor receptor family, which have intrinsic tyrosine kinase activity. Both EGFR and c-erbB2 genes are amplified in a number of tumours, including gastric cancer (Lemoine et al, 1991) . Phosphorylation of β-catenin, possibly through interaction with EGFR and c-erbB2, is thought to induce a disassembly of the E-cadherin-catenin complex from the actin filament network thus disruption of cell adhesion and may in turn potentiate the neoplastic process (Shibamoto et al, 1994) . The demonstration of an APC-β-catenin interaction raised much speculation as to the role of APC in regulating signal transduction through the β-catenin interaction with the cytoskeleton, thereby regulating some aspect of cell adhesion or cell growth (Rubinfeld et al, 1993; Su et al, 1993) . APC has been shown to be important in regulating cytoplasmic β-catenin levels (Munemitsu et al, 1995) . The APC-β-catenin complex is translocated into the nucleus where it interacts with the nuclear transcription factors LEF-1 and hTcf-4 (Korinek et al, 1997) , resulting in transcriptional activation. Truncation of the carboxy-terminal domain of the wild-type APC protein, in tumours containing APC gene mutations (Munemitsu et al, 1995) results in accumulation of cytoplasmic β-catenin, which is thought to contribute to the inappropriate activation of target genes by the β-catenin-LEF-TCF complex.
γ-catenin bears homology to β-catenin and is identical to desmosomal plakoglobin. p120 ctn is the most recently discovered member of the catenin family. It is phosphorylated by pp60 v-src , a tyrosine kinase known to be associated with the adherens junction (Volberg et al, 1992) , and which induces disruption of adherens junctions and epithelial cell transformation when overexpressed.
p120 ctn is also tyrosine phosphorylated in response to stimulation by mitogenic stimuli, including epidermal growth factor (EGF) and colony-stimulating factor 1 (CSF1; Downing and Reynolds, 1991) . These observations have suggested a role for p120 ctn in cell transformation and ligand-induced signalling. The existence of multiple p120 ctn isoforms is thought to represent a means for modulating E-cadherin function, by selective expression (Staddon et al, 1995) . A number of lines of evidence have implicated E-cadherin as a tumour suppressor. Deletions or mutations of E-cadherin result in disruption of adherens junction function and loss of calciumdependent cell-cell adhesion (Nagafuchi and Takeichi, 1988) . The chromosome 16q region and containing the E-cadherin gene is affected by loss of heterozygosity in breast and prostate cancers (Sato et al, 1990; Bergerheim et al, 1991; Carter et al, 1991) . Functional disturbance of the adherens junction may, however, also result from defects of catenin structure and function Kawanishi et al, 1995) . In vivo studies have demonstrated reduced immunoreactivity of E-cadherin, α-and β-catenin in a wide variety of tumours (Shiozaki et al, 1991 (Shiozaki et al, , 1994 , including breast (Oka et al, 1993) , gastric (Shimoyama and Hirohashi, 1991) , (Matsuura et al, 1992; Becker et al, 1993 Becker et al, , 1994 , colorectal (Nigam et al, 1993) , pancreatic (Pignatelli et al, 1994) and urogenital cancers (Umbas et al, 1992 ). An inverse relationship to tumour grade and stage was noted (Oka et al, 1993; Pignatelli et al, 1994) and in some cases a correlation with reduced survival (Umbas et al, 1992; Bringuier et al, 1993; Jawhari et al, 1997) .
Transformation from a normal epithelial cell to a malignant cell is thought to be a multistep process and results from accumulation of multiple gene abnormalities. A number of genetic and chromosomal defects have been described in gastric carcinoma, but no unifying hypothesis for the development of this tumour has emerged (Tahara, 1995) . Somatic E-cadherin mutations have been described in up to 50% of diffuse-type gastric tumours and 14% of mixed type tumours, but not intestinal tumours (Becker et al, 1993) . A recent study reported a germline E-cadherin mutation leading to a truncated gene product, responsible for early onset, poorly differentiated gastric cancer in a large kindred from New Zealand (Guilford et al, 1998) . Inactivating E-cadherin mutations were also identified in other gastric cancer families as well as somatic mutations in a number of sporadic gastric cancers, suggesting an important role for E-cadherin in the pathogenesis of gastric cancer.
To elucidate the role of the E-cadherin-catenin complex in gastric carcinoma, we examined expression and function of complex components in a panel of gastric carcinoma cell lines. Our results demonstrate evidence of aberrant expression and function of this complex in four of these cell lines.
MATERIALS AND METHODS

Cell lines
Kato 3, AGS, HT29 and MDCK, were obtained from the European tissue culture collection. MKN7 and MKN45 were obtained from Riken Cell Bank, Ibaraki, Japan, by kind permission of the originator, Dr Teiichi Motoyama. HSC39 and HSC40a were kindly donated by the originator, Dr Kazuyoshi Yangihara.
Kato III is a cell line derived from a metastatic pleural effusion secondary to signet ring carcinoma of the stomach. MKN45 is derived from a moderate to poorly differentiated intestinal type gastric carcinoma, while MKN7 is derived from a well-differentiated, intestinal-type gastric carcinoma. HSC39 was derived from malignant ascites arising secondary to a signet ring carcinoma, while HSC40a was established from the same original tumour after xenotransplantation of ascitic tumour cells into an athymic BALB/c nude mouse.
Growth and maintenance of cells
Cells lines were maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco BRL) supplemented with 10% heat inactivated, mycoplasma screened fetal calf serum (Gibco). The cells were cultured at 37ЊC in a humidified atmosphere containing 10% carbon dioxide. Cells were tested for mycoplasma at 3-monthly intervals.
Antibodies
Mouse monoclonal IgG antibodies to E-cadherin, α-, β-and γ-catenin and p120 ctn , were purchased from Affinity Research Products Ltd, Exeter, UK. Two antibodies to the EGFR were used, EGFR1 a mouse monoclonal antibody, and 12E a rabbit polyclonal antibody, were kindly donated by Professor W Gullick (Imperial Cancer Research Fund (ICRF), London) (Wilding et al, 1996) . The APC antibody, Ab28, was kindly donated by Sir Walter Bodmer (ICRF) (Efstathiou et al, 1998) .
Immunofluoresence staining of cultured cells
Cells were grown on multiwell slides (Hendley, Essex, UK), and fixed in 50:50 mixture of methanol and acetone at Ϫ 20 C for 20 min. Incubation with primary antibodies was performed overnight at 4ЊC. After washing in phosphate-buffered saline (PBS), the slides were incubated with biotinylated speciesspecific IgG for 30 min (Dako Ltd, High Wycombe, UK). After further washes in PBS, the slides were incubated in fluorescence isothiocyanate (FITC)-labelled avidin (Vector Laboratories, Peterborough, UK) for 10 min. Slides were mounted in Vecta shield (Vector Laboratories). For negative controls, primary antibody was replaced with mouse IgG.
Cell aggregation assay
The assay was performed as described by Takeichi (1977) with modifications. Single cell suspensions were prepared by incubation in non-enzymatic dissociation media (Sigma-Aldrich Company Ltd., Poole, UK) for 10 min at 37ЊC. The dissociated cells were washed twice in calcium-and magnesium-free medium and suspended in either calcium-and magnesium-free medium, or normal calcium containing medium at a concentration of 1 ϫ 10 6 cell ml Ϫ1 . The cells were then transferred to 50-ml Falcon tubes, preincubated with bovine serum albumin to reduce cells adhering to the plastic. The cell suspension was incubated on a gyratory shaker at 37ЊC. The number of single cells were counted at time 0 and at 15 min intervals during the experiment using a size-gated Coulter counter (Coulter Electronics, UK). Cell aggregation is represented by the aggregation index, N t /N 0 , which represents the ratio of single particles at time t of incubation to the initial single particle number at time 0. The aggregation index is plotted on the y-axis against time on the x-axis.
Immunoprecipitation
Cell extracts were prepared by lysis on ice, with 0.5% Triton X-100 buffer [50 mM sodium chloride (NaCl), 10 mM Pipes, 3 mol magnesium chloride (MgCl 2 ), 300 mM sucrose] with added protease inhibitors, as described above. Preclearing of cell extracts was performed using mouse IgG (2 µg ml Ϫ1 of cell extract), to reduce non-specific binding. Protein G sepharose beads (50 µl) (Pharmacia Biotech, St Albans, UK) were prewashed in lysis buffer, and incubated with cell extract in the presence of mouse IgG (2 µl), for 1 h at 4ЊC on a rotator. The slurry was then centrifuged, and the cell extract transferred to a new tube containing protein G (50 µl), prewashed and incubated in the presence of antibody (2 µl), for 2 h at 4ЊC on a rotator. The samples were sequentially washed with high stringency buffer (15 mM Tris-HCl, 5 mM EDTA, 2.5 mM EGTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulphate (SDS), 120 mM NaCl, 25 mM potassium chloride), high salt buffer (15 mM Tris-HCl, 5 M EDTA, 2.5 mM EGTA, 1% Triton X-100, 1% sodium deoxycholate, 1% SDS, 1 M NaCl) and low salt buffer (15 mM Tris-HC1, 5 mM EDTA). Wash buffer was aspirated with a needle and the precipitated proteins eluted from the beads under reducing conditions by boiling in Laemmli sample buffer for 5 min. Composition of the eluted protein complexes was analysed by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting. To confirm immunoprecipitation results and ascertain that lysis and wash conditions did not influence reported protein-protein interactions, cell lysis was also performed using the milder NP-40 buffer (50 mM Tris pH 7.5, 100 mM NaCl, 0.5% NP-40, 0.2 mM Na 3 VO 4 , 50 mM NaF). Protein G beads were subsequently washed gently using this same buffer (data not shown).
SDS-PAGE and Western blotting
Cell extracts were prepared using Laemmli sample buffer (715 mM 2-β-mercaptoethanol, 10% glycerol, 2% SDS, 40 mM Tris pH 6.8, 1 mM EDTA; Laemmli, 1970) , with a protease inhibitor cocktail (aprotinin 0.1-2 µg ml Ϫ1 , leupeptin 0.5-2 µg ml Ϫ1 , PMSF 20-100 µg ml Ϫ1 , trypsin-chymotrypsin inhibitor 10 µg ml Ϫ1 , TPCK 100 µg ml Ϫ1 (all from Sigma-Aldrich Company Ltd, Poole, UK). Sample protein concentration was determined by BioRad protein assay (BioRad, Hemel Hempstead, UK), using spectrophotometry. SDS-PAGE was performed under reducing conditions using an 8% acrylamide resolving gel, pH 8.8, overlaid with a 4.5% stacking gel pH 6.8. The separated proteins were transferred to nitrocellulose (Millipore, UK), using BioRad apparatus. Visualization of protein bands was achieved by incubation in primary antibody overnight followed by extensive washing, and then in horseradish peroxidase-labelled, secondary species-specific antibody (Dako Ltd, High Wycombe, UK). The membrane was developed in ECL chemiluminescent reagent (Amersham Life Science, Slough, UK) and exposed to X-ray film.
RESULTS
Functional assessment of cadherin-mediated intercellular adhesion in six gastric carcinoma cell lines
Cadherin function is reflected by the cell phenotype when grown in culture and can be quantitatively measured using a cell-cell aggregation assay. HT29 is a colon carcinoma cell line, which forms a typical polygonal cell sheet in culture, characteristic of epithelial cells. Previous characterization of the cadherin-catenin complex in HT29 has established this to be intact. It was therefore used as control.
Cell morphology and phenotype was assessed using phase contrast microscopy, under standard cell culture conditions. Kato 3 cells grow as single cells or small cell aggregates floating in suspension with a few scattered round cells adhering to the plastic. HSC39 and HSC40a also grow in vitro as a suspension of single cells or as loosely associated aggregates with no adherence to plastic, while MKN45 grows as a loosely adherent monolayer with spindle-shaped cells exhibiting poor cell-cell contact. MKN7 and AGS both grow as flat coherent monolayers. Impaired cell-cell adhesion was therefore apparent at phase contrast microscopy of cells in culture, in four of the six gastric cell lines. 
Figure 1
Western blotting results for APC, E-cadherin, α-, β-and γ-catenin in five gastric carcinoma cell lines. The results of Western blotting for APC, E-cadherin, α-, β-and γ-catenin are shown. Each lane represents a different cell line. Aberrant E-cadherin expression is seen in Kato 3, consistent with a previously described mutation. AGS expressed very low levels of E-cadherin and no α-catenin. A truncated β-catenin is seen in HSC39 and HSC40A, both derived from the same tumour. γ-Catenin is normally expressed in all cell lines. A truncated APC protein product is seen in HT29 and no APC is expressed by Kato 3
Functional assessment of calcium-dependent cell-cell adhesion was performed using a cell-cell aggregation assay as described by Takeichi et al (1997) with modifications. In the presence of a normally functioning cadherin-catenin complex as seen in MDCK and HT29 there was a progressive fall in the number of single cells with time (65% at 1 h). This is demonstrated by a fall in aggregation index to 0.35 at 90 min in calcium-containing medium. The aggregation index is calculated as the number of single cells at time ϫ number of single cells at time 0. Cadherin-dependent cell-cell adhesion in HT29 is abolished by incubation of cells in calcium-free media, with no change in the aggregation index occurring with time. No calcium-dependent cell-cell aggregation could be demonstrated, in any of the gastric carcinoma cell lines suggesting impairment of E-cadherin-mediated intercellular adhesion in these cell lines.
Expression of E-cadherin and the catenins in gastric carcinoma cell lines
Aberrant expression of E-cadherin and/or catenins was demonstrated in a number of the cell lines examined. Western blot analysis (Figure 1 ) revealed very low levels of E-cadherin in AGS, which were often barely discernible in repeat experiments. Aberrant E-cadherin expression was detected in Kato 3 and MKN45. Two protein bands reactive for E-cadherin were detected in Kato 3, one at 120 kDa, and a second at a 130 kDa. MKN45 demonstrated one band at the expected molecular weight of 120 kDa and the second at 80 kDa, which is likely to represent the extracellular tryptic product of E-cadherin as previously described (Frixen et al, 1991) . E-cadherin was detected at the expected molecular weight of 120 kDa in HSC39, HSC40A and MKN7, although levels of E-cadherin expression were lower in MKN7 compared to control (HT29) and other gastric carcinoma cell lines.
α-catenin expression was absent in AGS, but expressed at the expected molecular weight of 102 kDa in the remaining five cell lines, although levels were reduced in three of these cell lines, Kato 3, HSC39 and HSC40A, compared to control. β-catenin was truncated at 80 kDa in HSC39 and HSC40A, as previously described by the originators (Kawanishi et al, 1995) . Finally, all six cell lines expressed γ-catenin and p120 ctn (data not shown) in comparable amounts and at the expected molecular weight. A band at 300 kDa immunoreactive for APC was detected in all but one cell line, Kato 3, which was negative for APC, suggesting the probable presence of a mutation of the APC gene. A truncated APC protein migrating at 200 kDa was detected in HT29, confirming a previously described mutation.
Cellular localization of E-cadherin and the catenins in gastric carcinoma cell lines
Staining results are summarized in Table 1 . Immunofluoresence staining in the control cell line, HT29, revealed co-localization of E-cadherin and the catenins at the cell membrane, with increased staining intensity at points of cell-cell contact consistent with adherens junctions. Diffuse cytoplasmic and nuclear staining was additionally observed with β-catenin, reflecting its now known role as transcriptonal regulator. E-cadherin membranous staining was absent in AGS, and patchy with low intensity in MKN7. These findings agree with Western blotting data showing absent and reduced levels of Ecadherin in these cell lines respectively. Linear membranous staining was present, however, in the remaining four gastric carcinoma cell lines, including Kato 3 and MKN45, which had aberrant E-cadherin expression on Western blotting. Loss of membranous staining for α-catenin was seen in Kato 3 and HSC39, HSC40a and AGS. There was patchy membranous staining for β-and γ-catenin in Kato 3, while staining was cytoplasmic in HSC39, HSC40a and AGS. p120 ctn stained in a membranous distribution in all cell lines. Loss of membranous localization of either E-cadherin or the catenins, implies corresponding loss of their adhesive function, though disruption of adherens junctions.
Staining for the EGFR revealed intense membranous distribution in Kato 3, and faint membranous staining with a punctate pattern in MKN7 and MKN45. It was absent in AGS, HSC39 and HSC40a. 
Protein interactions within the cadherin-catenin complex in gastric carcinoma cell lines
We examined protein interactions within the cadherin-catenin complex, using sequential immunoprecipitation and immunoblotting with E-cadherin, α-, β-, γ-catenin, p120 ctn , EGFR and APC antibodies. The protein concentration of cell extracts was measured by BioRad protein assay and equal aliquots were each mixed with the immunoprecipitating antibody. Immune complexes are formed consisting of the immunoprecipitating antibody, its antigen and any other protein, which binds to primary antigen to form a multimolecular complex. The immunoprecipitates are then captured using protein G beads, which are washed, and the protein components of the complexes eluted into suspension and then separated under reducing conditions by SDS-PAGE and Western blotting. The presence of interacting proteins can then be detected by probing the nitrocellulose blots with a panel of antibodies to components of the cadherin catenin complex (see diagramatic representation, Figure 2 ).
HT29 was used to demonstrate the normal composition of the cadherin-catenin complex (Figure 3) . The figure consists of four Western blots for E-cadherin, α-, β-and γ-catenin performed on HT29 cell extracts after immunoprecipitation with the antibody shown above the panel. E-cadherin was co-immunoprecipitated with β-and γ-catenin and, to a lesser extent, with α-catenin antibodies suggesting the presence of a binding interaction between these proteins (top panel). α-catenin was precipitated with both β-catenin and γ-catenin (second panel), while both β and γ-catenin were immunoprecipitated in small quantities by EGFR antibodies. These findings are in agreement with published data suggesting that E-cadherin forms a complex with β-or γ-catenin which in turn bind to α-catenin (Ozawa and Kember, 1992) . p120 ctn has been shown to bind directly to E-cadherin (Reynolds, 1994) , although in our hands, this interaction appeared to be highly sensitive to lysis and wash conditions, and only demonstrable when using very mild non-ionic conditions. EGFR has been shown to interact directly with β-and γ-catenin (Hoschuetzky et al, 1994) . In each experiment a negative control immunoprecipitation with non-immune mouse IgG was performed.
Abnormalities of complex composition were demonstrated in a number of gastric cell lines. Kato 3, which is known to have an Ecadherin mutation, demonstrated significantly reduced binding of E-cadherin to β-catenin compared to other cell lines (Figure 4 , lane 5). Lane 3 represents the total amount of E-cadherin precipitated Figure 4 E-cadherin Western blots of gastric cell line extracts after sequential immunoprecipitation with E-cadherin, catenin and EGFR antibodies. Cell extracts indicated to the right were immunoprecipitated with antibodies to E-cadherin, α-β-and γ-catenin, p120 ctn , and EGFR as indicated above. Precipitated proteins were separated by SDS-PAGE and subjected to Western blotting for the presence of E-cadherin in the immunoprecipitates. E-cadherin binding to β-catenin was significantly reduced in Kato 3 (second panel, lane 5) relative to the total amount of E-cadherin precipitated by E-cadherin antibodies (lane 3), and no E-cadherin was detectable in γ-catenin immunoprecipitates in this cell line (second panel, lane 6). Ecadherin binding to p120 ctn could not be demonstrated in Kato 3, MKN7 and MKN45 (lane 7). AGS fails to express E-cadherin, so as expected no proteins could be demonstrated in the immunoprecipitates (panel 5). Lane 1 is a positive control I/P with β-catenin antibodies, while lane 2 is a negative control I/P with mouse IgG by E-cadherin antibodies in a parallel experiment performed simultaneously. In other words, only a small proportion of the total amount of E-cadherin (lane 3), could be precipitated with β-catenin antibodies (lane 5). This can be compared to the equal Ecadherin band densities arising from immunoprecipitation with E-cadherin or β-catenin antibodies in the other cell lines, suggesting that the majority of the β-catenin in these cell lines is E-cadherin bound. Equal amounts of cell extract protein, and immunoprecipitating antibody were used in each experiment, making a comparison of band density for a particular protein between cell lines possible. AGS, which is negative for E-cadherin on Western blotting, showed no E-cadherin protein on immunoprecipitation with E-cadherin or catenin antibodies. E-cadherin binding to p120 ctn also appeared to be disrupted in Kato 3, MKN7 and MKN45 (Figure 4, lane7 ). E-cadherin was present in EGFR immunoprecipitates in three cell lines, HT29, HSC39 and MKN7. This is an unexpected finding and may represent an indirect interaction of E-cadherin with EGFR, through β-catenin, due to precipitation of higher order complexes. In some of our immunoprecipitation experiments separation of β-catenin and γ-catenin into two distinct complexes was apparently not complete, with β-catenin and γ-catenin appearing in the reciprocal immunoprecipitations ( Figure 5, lane 6) . In addition, β-catenin was immunoprecipitated with p120 ctn antibodies immunoprecipitates ( Figure 5, lane 7) , and E-cadherin with EGFR ( Figure 4 , lane 8). These unexpected interactions may reflect co-immunoprecipitation of a minor subpopulation of 'higher order complexes'.
On immunoprecipitation with APC antibodies, β-catenin was seen to be present in the immunoprecipitates in all cell lines apart from Kato 3, which we have shown to have loss of APC expression ( Figure 6 ). This suggests preservation of the APC-β-catenin interaction in these cell lines even in the presence of a truncated β-catenin protein as in HSC39.
DISCUSSION
Loss of cadherin-mediated intercellular adhesion is an important contributory mechanism in tumour pathogenesis. It is postulated to remove contact inhibition of proliferation, thus allowing escape from growth control signals (St Croix et al, 1998) . Loss of cadherinmediated adhesion may also act by potentiating tumour cell detachment from the primary site, and resulting in dissemination of malignant cells to form metastases at distant sites (Birchmeier et al, 1993) . E-cadherin is thus postulated to act both as a growth suppressor and invasion suppressor. An intact cadherin-catenin complex is required, however, for maintenance of normal intercellular adhesion, with mutations of either E-cadherin or α/β-catenins being sufficient to disrupt adherens junction function. antibodies to E-cadherin, α-, β-and γ-catenin, p120 cas and EGFR as indicated above the panels. Precipitated proteins were separated by SDS-PAGE and subjected to Western blotting for the presence of β-catenin in the immunoprecipitates. β-Catenin was immunoprecipitated with E-cadherin in all cell lines apart from AGS, which fails to express the E-cadherin protein (lane 5). The truncated β-catenin protein (80 kDa) in HSC39 fails to immunoprecipitate with α-catenin or EGFR (third panel, lanes 4 and 8). Lane 1 is a negative control I/P using mouse IgG, while lane 2 is a positive control I/P using β-catenin antibodies
In this study, examination of cell morphology, protein expression and localization, and molecular organization of the cadherin-catenin complex in six gastric carcinoma cell lines have demonstrated evidence of widespread dysfunction of calciumdependent intercellular adhesive mechanisms. E-cadherin is the principal mediator of intercellular adhesion, and adherens junction integrity in epithelial cells. When it functions normally, disruption of other intercellular adhesion molecules has little effect on adhesive function. Four of the six cell lines tested showed morphological evidence of reduced intercellular adhesion, while all failed to demonstrate any evidence of calcium-dependent intercellular adhesion when examined in a cell-cell aggregation assay.
A variety of mutations in the cadherin-catenin system have previously been described in a number of these cell lines. We confirm these defects, and additionally demonstrate loss of expression of some components of the complex. By a detailed examination of protein expression, cellular localization by immunocytochemisty, and co-immunoprecipitation analysis to assess protein-protein interactions within the cadherin-catenin complex, we have identified putative defects in the corresponding adhesion systems.
Kato III is known to have an E-cadherin point mutation, resulting in the production of aberrant mRNA, which is manifested by the presence of two E-cadherin bands on Western blotting, at 120 and 130 kDa (Oda et al, 1994) . E-cadherin dysfunction in Kato III secondary to mutation is demonstrable by its tendency to grow as free-floating cells with little tendency towards calciumdependent cell-cell aggregation. Immunoprecipitation experiments revealed reduced E-cadherin binding to β-catenin and no binding to γ-catenin, suggesting disruption of cadherin-catenin complex integrity. These abnormalities were associated with reduced intensity and heterogeneity of staining for the catenins at cell borders. It seems likely that the E-cadherin mutation results either in loss of the catenin-binding site or steric changes interfering with binding to the catenins, and hence loss of catenin localization to the adherens junction and interruption of the adherens junction link to the actin cytoskeleton.
An E-cadherin mutation has also been described in MKN45 (Oda et al, 1994) , in this case at the extracellular calcium-binding domain. This would explain the loss of cell-cell aggregation despite the continued normal expression of both E-cadherin and catenins at the cell membrane and the normal protein interactions with the catenins. The lower molecular weight band in the Ecadherin blot thought to represent the extracellular tryptic product of E-cadherin as previously described (Frixen et al, 1991) .
MKN7 also demonstrated total loss of cell-cell aggregation despite expression of all components of the cadherin-catenin complex at the expected molecular weights and normal membranous localization. E-cadherin levels were low compared to other cell lines and to control, both on Western blotting and immunocytochemical staining. On immunoprecipitation with E-cadherin antibodies, the only aberration in protein interactions was failure to demonstrate the expected binding of p120 ctn to E-cadherin, the significance of which is uncertain. The explanation for impaired intercellular adhesion is less obvious in this cell line. A point mutation in the E-cadherin, or catenin genes has not been excluded.
HSC39 has previously been shown to have a β-catenin mutation resulting in protein truncation with loss of the α-catenin-binding site (Kawanishi et al, 1995) . This is demonstrated by loss of the E-cadherin-β-catenin interaction with α-catenin ( Figure 5 , lane 4, panel 3), which in turn links it to the actin cytoskeleton.
Immunofluoresence staining demonstrated diffuse cytoplasmic staining of the catenins with loss of membranous localization, suggesting failure to associate with E-cadherin at the cell membrane. These abnormalities in the cadherin-catenin complex are reflected by loss of calcium-dependent cadherin-mediated cell-cell adhesion, and by failure of cells to form a monolayer in culture.
AGS showed failure of E-cadherin and α-catenin on Western blotting and immunocytochemical staining. Loss of α-catenin expression may be secondary to loss of E-cadherin. Previous data have suggested that E-cadherin confers stability on α-catenin, in the absence of which it is broken down in the cytoplasm. Normal β-catenin expression was seen on Western blotting, but this was totally cytoplasmic in distribution. This is not surprising as its location at the cell membrane depends on binding to E-cadherin, which in the case of AGS fails to be expressed. p120 ctn binds to the juxtamembranous region of the E-cadherin cytoplasmic tail, which has been shown to support the lateral clustering of E-cadherin molecules at the cell surface. p120 ctn is thought to act as an intermediary binding protein allowing clustering of E-cadherin at the cell surface, a function which allows modulation of adhesive strength under different cirmumstances (Yap et al, 1998) . We found the E-cadherin-p120 ctn interaction to be highly sensitive to lysis and buffer conditions, with easy disruption of the complex. The continued membranous localization of p120 ctn in all the cell lines, suggests maintenance of its normal binding relationship with E-cadherin, as its membranous localization depends on this relationship.
Apart from binding to E-cadherin at the cell membrane, a significant proportion of the catenin pool is free cytoplasmic protein, or exists in the form of cadherin-independent α/β-catenin, or α/γ-catenin complexes. These complexes are thought to influence the titration of catenins between cadherin and APC complexes. Mutagenesis studies have shown that for tumour formation to ensue, truncation of the APC protein must include loss of that part of the protein responsible for the ability to down-regulate β-catenin. The resulting increase in cytoplasmic β-catenin levels, and the ensuing increased translocation to the nucleus, results in autonomous transcription of Tcf target genes, known to be specific to colonic epithelium, and thus contributes to neoplastic transformation.
Mutations of the amino terminal regulatory domain of β-catenin have been demonstrated in 48% of colorectal tumours lacking APC mutations (Sparks et al, 1998) . Mutations in this area of the protein render it insensitive to APC-mediated degradation. β-catenin mutations were also present in a similar proportion of colorectal adenomas suggesting that like APC, these mutations arise early in tumorigenesis. In an exciting recent discovery, one of the cancer-promoting genes at the end of the β-catenin signal transduction pathway has been shown to be the oncogene c-myc (Sparks, et al, 1998) . Wild-type APC is thought to prevent β-catenin from forming a complex with Tcf-4 and activating c-myc expression. But when APC is mutated, β-catenin accumulates and is translocated to the nucleus where it results in sustained transcriptional activation of certain genes, including c-myc, and causes tumour growth. This is a rare example of loss of a tumour suppressor gene resulting in activation of an oncogene. The APC gene is mutated in up to 20% of gastric carcinomas and in a similar proportion of gastric adenomas (Horii et al, 1992; Tamura et al, 1994) . The data presented in this study demonstrate preservation of the APC-β-catenin interaction in 5 gastric carcinoma cell lines even in the presence of a truncated β-catenin protein as in HSC39.
In conclusion, we have demonstrated frequent abnormalities of expression and function of the cadherin-catenin complex, correlated with evidence of impaired protein-protein interactions within the cadherin-catenin complex. These abnormalities manifest with disturbance of cadherin-mediated intercellular adhesion in gastric carcinoma cell lines. While the defects demonstrated were heterogeneous, affecting E-cadherin, α and β-catenin, the functional result was similar, that of loss of cadherin-mediated cell-cell adhesion. These findings support previously reported in vivo findings of a role for inactivation of E-cadherin-mediated intercellular adhesion in the pathogenesis and progression of gastric carcinoma.
